Evidence map›Paper›PMID 23109177›Full record

ArticleCell biochemistry and biophysics2013

Bumetanide hyperpolarizes madin-darby canine kidney cells and enhances cellular gentamicin uptake by elevating cytosolic Ca(2+) thus facilitating intermediate conductance Ca(2+)--activated potassium channels.

Tian Wang, Yu-Qin Yang, Takatoshi Karasawa, Qi Wang, Amanda Phillips, Bing-Cai Guan, Ke-Tao Ma, Meiyan Jiang, Ding-Hua Xie, Peter S Steyger and 1 more

Open access · greenAbstract read
In one paragraph

Article in Cell biochemistry and biophysics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Tian WangOregon Hearing Research Center, NRC04, Department of Otolaryngology, Oregon Health & Science University, Portland, OR 97239, USA.
Yu-Qin Yang
Takatoshi Karasawa
Qi Wang
Amanda Phillips
Bing-Cai Guan
Ke-Tao Ma
Meiyan Jiang
Ding-Hua Xie
Peter S Steyger
Zhi-Gen Jiang
Oregon Health & Science University · USCentral South University · CNHebei Medical University · CN

Funding

PORTLAND AREA COMMUNICATION RESEARCH CORE CENTERP30DC005983 · NIDCD · OREGON HEALTH & SCIENCE UNIVERSITY · PI NUTTALL, ALFRED L · 2003 to 2017
$9.0M
HAIR CELL RESPONSES TO OTOTOXIC DRUGSR01DC004555 · NIDCD · OREGON HEALTH & SCIENCE UNIVERSITY · PI STEYGER, PETER STEPHEN · 2001 to 2020
$6.6M
Cellular electrophysiology of vasculatures in inner earR01DC004716 · NIDCD · OREGON HEALTH & SCIENCE UNIVERSITY · PI JIANG, ZHI-GEN · 2003 to 2013
$2.8M
Identification of gentamicin-binding proteins in the inner earR03DC009501 · NIDCD · OREGON HEALTH & SCIENCE UNIVERSITY · PI KARASAWA, TAKATOSHI · 2008 to 2010
$460k
Functional similarities in renal and cochlear epitheliaR21DC006084 · NIDCD · OREGON HEALTH AND SCIENCE UNIVERSITY · PI STEYGER, PETER S · 2003 to 2004
$299k
NIDCD NIH HHS P30 DC005983NIDCD NIH HHS P30 DC05983NIDCD NIH HHS R01 DC004555NIDCD NIH HHS R01 DC004716NIDCD NIH HHS R01 DC04555NIDCD NIH HHS R01 DC04716NIDCD NIH HHS R03 DC009501NIDCD NIH HHS R21 DC06084
6 · The paper itself

Abstract

Loop diuretics such as bumetanide and furosemide enhance aminoglycoside ototoxicity when co-administered to patients and animal models. The underlying mechanism(s) is poorly understood. We investigated the effect of these diuretics on cellular uptake of aminoglycosides, using Texas Red-tagged gentamicin (GTTR), and intracellular/whole-cell recordings of Madin-Darby canine kidney (MDCK) cells. We found that bumetanide and furosemide dose-dependently enhanced cytoplasmic GTTR fluorescence by ~60 %. This enhancement was suppressed by La(3+), a non-selective cation channel (NSCC) blocker, and by K(+) channel blockers Ba(2+) and clotrimazole, but not by tetraethylammonium (TEA), 4-aminopyridine (4-AP) or glipizide, nor by Cl(-) channel blockers diphenylamine-2-carboxylic acid (DPC), niflumic acid (NFA), and CFTRinh-172. Bumetanide and furosemide hyperpolarized MDCK cells by ~14 mV, increased whole-cell I/V slope conductance; the bumetanide-induced net current I/V showed a reversal potential (V r) ~-80 mV. Bumetanide-induced hyperpolarization and I/V change was suppressed by Ba(2+) or clotrimazole, and absent in elevated [Ca(2+)]i, but was not affected by apamin, 4-AP, TEA, glipizide, DPC, NFA, or CFTRinh-172. Bumetanide and furosemide stimulated a surge of Fluo-4-indicated cytosolic Ca(2+). Ba(2+) and clotrimazole alone depolarized cells by ~18 mV and reduced I/V slope with a net current V r near -85 mV, and reduced GTTR uptake by ~20 %. La(3+) alone hyperpolarized the cells by ~-14 mV, reduced the I/V slope with a net current V r near -10 mV, and inhibited GTTR uptake by ~50 %. In the presence of La(3+), bumetanide-caused negligible change in potential or I/V. We conclude that NSCCs constitute a major cell entry pathway for cationic aminoglycosides; bumetanide enhances aminoglycoside uptake by hyperpolarizing cells that increases the cation influx driving force; and bumetanide-induced hyperpolarization is caused by elevating intracellular Ca(2+) and thus facilitating activation of the intermediate conductance Ca(2+)-activated K(+) channels.

Indexed as

AnimalsBumetanideCalciumCalcium Channel BlockersCell PolarityDiureticsDogsGene Expression RegulationGentamicinsKineticsMadin Darby Canine Kidney CellsMembrane PotentialsPatch-Clamp TechniquesPotassium Channels, Calcium-ActivatedSodium-Potassium-Chloride SymportersSodium-Potassium-Exchanging ATPaseBumetanideCalciumCalcium Channel BlockersDiureticsGentamicinsPotassium Channels, Calcium-ActivatedSodium-Potassium-Chloride SymportersSodium-Potassium-Exchanging ATPaseTexas redTRPV Cation ChannelsXanthenes

Identifiers

PMID23109177
PMCPMC3584200
OpenAlexW2159962417

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.